REGENERON REPORTS POSITIVE PHASE 1 DATA FOR THE VEGF TRAP IN AGE-RELATED MACULAR DEGENERATION Preliminary results show improvements in vision and retinal swelling VEGF Trap was well tolerated at all dose levels Company also announces initiation of phase 2 trial
Tuesday, May 2, 2006 1 min read
Key Takeaway: REGENERON REPORTS POSITIVE PHASE 1 DATA FOR THE VEGF TRAP IN AGE-RELATED MACULAR DEGENERATION Preliminary results show improvements in vision and retinal swelling VEGF Trap was well tolerated at all dose levels Company also announces initiation of phase 2 trial
Full Press Release Details
REGENERON REPORTS POSITIVE PHASE 1 DATA FOR THE VEGF TRAP IN AGE-RELATED MACULAR DEGENERATION Preliminary results show improvements in vision and retinal swelling VEGF Trap was well tolerated at all dose levels Company also announces initiation of phase 2 trial.